Clinical research has demonstrated that PAK1 not only participates in the tumorigenicity of diverse cancers [23] but also modulates autophagy levels through the Akt/mTOR or Erk/mTOR signaling pathway [24, 25]. This evidence concerns the gene AKT1 and cancer.